RE:Announcement
Agree - I am intrigued since I wonder what implications this has with respect to the Innovosil-1 compound, and the majority stake in Nou Life. Just from a contract research perspective, they now have two labs; assuming this one is similar in size to Innovotech, that is a doubling of contract research revenue potentially? With the high margins (> 70%), this hopefully can fall to the bottom line nicely.
In the press release, they say "A further comprehensive press release will be issued upon the signing of a definitive agreement with respect to the Keystone acquisition", so look forward to more colour soon!